{
    "organizations": [],
    "uuid": "1e9a540427bdb49778b3a6d6bf17b4fb508ef9fe",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-trial-shows-pfizers-lyrica-reduces/brief-trial-shows-pfizers-lyrica-reduces-seizures-in-children-with-epilepsy-idUSASC0A2RB",
    "ord_in_thread": 0,
    "title": "BRIEF-Trial shows Pfizer's Lyrica reduces seizures in children with epilepsy",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 17 (Reuters) - Pfizer Inc:\n* LYRICAÂ® (PREGABALIN) ORAL SOLUTION CV PHASE 3 TRIAL IN PEDIATRIC EPILEPSY MEETS PRIMARY ENDPOINT\n* PFIZER - POSITIVE TOP-LINE RESULTS OF PHASE 3 STUDY EXAMINING USE OF LYRICA ORAL SOLUTION CV AS ADJUNCTIVE THERAPY\n* PFIZER - RESULTS SHOWED ADJUNCTIVE TREATMENT WITH LYRICA 14 MG/KG/DAY RESULTED IN STATISTICALLY SIGNIFICANT REDUCTION IN SEIZURE FREQUENCY VERSUS PLACEBO\n* PFIZER INC - TREATMENT WITH LYRICA AT LOWER DOSE DID NOT RESULT IN STATISTICALLY SIGNIFICANT REDUCTION IN SEIZURE FREQUENCY VERSUS PLACEBO Source text for Eikon: Further company coverage:\n ",
    "published": "2018-05-17T20:23:00.000+03:00",
    "crawled": "2018-05-18T19:40:53.001+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "pfizer",
        "inc",
        "pregabalin",
        "oral",
        "solution",
        "cv",
        "phase",
        "trial",
        "pediatric",
        "epilepsy",
        "meet",
        "primary",
        "endpoint",
        "pfizer",
        "positive",
        "result",
        "phase",
        "study",
        "examining",
        "use",
        "lyrica",
        "oral",
        "solution",
        "cv",
        "adjunctive",
        "therapy",
        "pfizer",
        "result",
        "showed",
        "adjunctive",
        "treatment",
        "lyrica",
        "resulted",
        "statistically",
        "significant",
        "reduction",
        "seizure",
        "frequency",
        "versus",
        "placebo",
        "pfizer",
        "inc",
        "treatment",
        "lyrica",
        "lower",
        "dose",
        "result",
        "statistically",
        "significant",
        "reduction",
        "seizure",
        "frequency",
        "versus",
        "placebo",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}